Cortellis

Identifying and evaluating new products to rise above the competition

Learn how the Business Development and Licensing team help Par Pharmaceutical rise above the competition by quickly and accurately identifying a shortlist of potential portfolio candidates, recognizing potential barriers to market entry, and monitoring the launch, API development and patenting activities of competitors worldwide.

Making data driven decisions with reliable intelligence

Johnson & Johnson experienced difficulties keeping up to date on the global drug pipeline and spent considerable time and expense gathering and analyzing data from multiple sources. Discover how Cortellis Competitive Intelligence helped the company apply reliable data to confidently make strategic decisions.

Securing the best price for an out-licensed asset

Biotech Ensysce seeks out-licensing or partnering opportunities around the world for its proprietary abuse and overdose resistant prodrug technologies. Learn how the company has made successful deals faster, without sacrificing due diligence, and negotiated a higher price than what it originally thought it could obtain.

Conducting pathway analyses to accelerate discovery research

Discover how researchers at Harvard University freed up the bioinformatics team by empowering biologists to analyze their own data, and made critical go/no-go decisions regarding which drugs to push through the development lifecycle by obtaining an understanding of omics data in the context of their therapeutic area

Drug repurposing for rare disease treatment leads to reduced risk

Director of the Drug Discovery Platform of Parc Científic Barcelona, Jordi Quintana and his team secured funding to investigate a rare disease, amyloidosis. They set out to study a subset of the disease called familial amyloid polyneuropathy. Because of the rare nature of the disease and the limited patient base, traditional drug discovery and development […]

Do EMA and FDA review outcomes for new active substances (NASs) align?

In order to better assure the safety and efficacy of pharmaceutical products, the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) have taken steps to align their activities and goals. The Centre for Innovation in Regulatory Science (CIRS) and Sanofi partner on a study to evaluate their progress to date.   The common […]

COVID-19: Scientific innovation will help us beat this virus

“Nothing in life is to be feared, it is only to be understood. Now is the time to understand more, so that we may fear less.” Marie Curie The Coronavirus (COVID-19) pandemic has taken the world by storm with over 380K+ cases confirmed worldwide and 16K+ deaths as of this writing.1 Although the word “pandemic” […]